FMT
ACAD icon

First Mercantile Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

First Mercantile Trust’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$77K Sell
4,639
-317
-6% -$6.11K 0.01% 721
2021
Q2 		$121K Buy
4,956
+2,722
+122% +$61.4K 0.01% 626
2021
Q1 		$58K Sell
2,234
-1,035
-32% -$45.6K 0.01% 765
2020
Q4 		$175K Sell
3,269
-371
-10% -$18.4K 0.02% 485
2020
Q3 		$182K Sell
3,640
-1,375
-27% -$59.4K 0.02% 445
2020
Q2 		$243K Sell
5,015
-1,754
-26% -$84.2K 0.03% 325
2020
Q1 		$286K Buy
6,769
+5,109
+308% +$211K 0.04% 250
2019
Q4 		$71K Buy
+1,660
New +$72.2K 0.01% 751
2014
Q2 		– Sell
-12,730
Closed -$310K – 1151
2014
Q1 		$310K Buy
+12,730
New +$322K 0.02% 717

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return